ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
D001275:ATP Citrate (pro-S)-Lyase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D000230:Adenocarcinoma / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality / Q000473:pathology; D045744:Cell Line, Tumor; D004789:Enzyme Activation; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality / Q000473:pathology; D051379:Mice; D010766:Phosphorylation; D011379:Prognosis; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics
D001275:ATP Citrate (pro-S)-Lyase; D051057:Proto-Oncogene Proteins c-akt